Canada Records Second Case Of Rare Blood Clot After AstraZeneca Shot

Canada reported its first case of blood clotting associated with low platelets on Tuesday in a Quebec woman who received the same shot.

Canadian health authorities said Saturday the country has recorded a second case of rare but serious blood clotting linked to AstraZeneca's Covid-19 vaccine, but still recommend the shot for use. The patient, who lives in the western province of Alberta and received a version of the AstraZeneca vaccine supplied by the Serum Institute of India, "has received treatment and is recovering," Canadian health authorities wrote on Twitter. Canada reported its first case of blood clotting associated with low platelets on Tuesday in a Quebec woman who received the same shot. Blood clot formations linked to the AstraZeneca vaccine "remain very rare" and Canada still believes that the vaccine's benefits "outweigh the potential risks," Health Canada and the Public Health Agency of Canada said.